Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.42 |
| ▸ | CA2 | P00918 | 6/20 | 0.42 |
| ▸ | EEF2K | O00418 | 2/20 | 0.36 |
| ▸ | EEF2 | P13639 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | PLK4 | O00444 | 1/20 | 0.36 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | TYK2 | P29597 | 1/20 | 0.36 |
| ▸ | FLT3 | P36888 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ITK | Q08881 | 1/20 | 0.36 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL15365843 | 0.98 | CA1 (0.41) | CA1CA2EEF2KEEF2MEN1 | |
| Iodide SCHEMBL180207 | 0.98 | CA1 (0.41) | CA1CA2EEF2KEEF2MEN1 | |
| Fluoride Ion SCHEMBL21980196 | 0.98 | CA1 (0.41) | CA1CA2EEF2KEEF2MEN1 | |
| Bromide SCHEMBL8204078 | 0.98 | CA1 (0.45) | CA1CA2EEF2KEEF2MEN1 | |
| Hydrochloric Acid SCHEMBL1884665 | 0.98 | CA1 (0.41) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL30779767 | 0.98 | CA1 (0.45) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL61368 | 0.92 | CA1 (0.38) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL15732264 | 0.92 | CA1 (0.38) | CA1CA2EEF2KEEF2MEN1 | |
| Iodide SCHEMBL5579282 | 0.92 | CA1 (0.38) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL28698378 | 0.92 | CA1 (0.38) | CA1CA2EEF2KEEF2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1879 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3251133-B1 | WIDE OPERATING TEMPERATURE RANGE (0° TO 275°C) ULTRACAPACITOR | FASTCAP ULTRACAPACITORS LLC (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4614540-A2 | CHIP FORM ULTRACAPACITOR | FastCAP Ultracapacitors LLC (US) | 2025-09-10 | — | — | EP | claimed |
| US-20250179894-A1 | POWER SYSTEM FOR HIGH TEMPERATURE APPLICATIONS WITH RECHARGEABLE ENERGY STORAGE | FASTCAP ULTRACAPACITORS LLC | 2025-06-05 | — | — | US | claimed |
| WO-2025089809-A1 | METHOD FOR MANUFACTURING SULFIDE-POLYMER HYBRID ELECTROLYTE MEMBRANE AND HYBRID ELECTROLYTE MEMBRANE MANUFACTURED THEREBY | 한국전기연구원 | 2025-05-01 | — | — | WO | claimed |
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | nanoSUR LLC | 2025-04-10 | — | — | US | claimed |
| US-20250069821-A1 | CHIP FORM ULTRACAPACITOR | FASTCAP ULTRACAPACITORS LLC | 2025-02-27 | — | — | US | claimed |
| US-12215572-B2 | Power system for high temperature applications with rechargeable energy storage | FASTCAP ULTRACAPACITORS LLC (US) | 2025-02-04 | — | — | US | claimed |
| CN-117895067-A | Self-healing gel polymer electrolyte, preparation method and application thereof, and polymer lithium battery | 吉林省东驰新能源科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-11923139-B2 | Energy storage device for high temperature applications | ENI S.P.A. (IT) | 2024-03-05 | — | — | US | claimed |
| CN-117551244-A | Block polymer, preparation method and application thereof, solid electrolyte and application thereof | 吉林省翰驰科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| WO-2006027070-A1 | METHOD FOR THE PRODUCTION OF HETEROCYCLIC QUATERNARY AMMONIUM COMPOUNDS AND/OR GUANIDINE COMPOUNDS HAVING HIGH PURITY | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | WO | claimed |
| US-20050287555-A1 | Uses of cationic salts for polynucleotide synthesis | AGILENT TECHNOLOGIES, INC. | 2005-12-29 | — | — | US | claimed |
| US-20050232981-A1 | Compositions capable of facilitating penetration across a biological barrier | CHIASMA, INC. | 2005-10-20 | — | — | US | claimed |
| WO-2005094785-A2 | COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER | CHIASMA, LTD. (IL) | 2005-10-13 | — | — | WO | claimed |
| US-20050136103-A1 | Transepithelial delivery of effectorsequentially coupled with a counter ion to the at least one effector and at least one pharmaceutically acceptable hydrophobic agent; translocation, encapsulation | CHIASMA, INC. | 2005-06-23 | — | — | US | claimed |
| US-20050058702-A1 | Compositions capable of facilitating penetration across a biological barrier | CHIASMA, INC. | 2005-03-17 | — | — | US | claimed |
| US-20040146549-A1 | Amino acid sequences capable of facilitating penetration across a biological barrier | CHIASMA, INC. | 2004-07-29 | — | — | US | claimed |
| US-20040009393-A1 | Electrolyte of lithium-sulfur batteries and lithium-sulfur batteries comprising the same | SAMSUNG SDI CO., LTD (KR) | 2004-01-15 | — | — | US | claimed |
| US-20030073005-A1 | Electrolyte for lithium-sulfur batteries and lithium-sulfur batteries comprising the same | SAMSUNG SDI CO., LTD. (KR) | 2003-04-17 | — | — | US | claimed |
| EP-1302997-A2 | An electrolyte for lithium-sulfur batteries and lithium-sulfur batteries containing the same | Samsung SDI Co., Ltd. (KR) | 2003-04-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | NSUN2, NSUN3, RNGTT | CA1 4858/4885CA2 4844/4885EEF2K 717/4885 |
| US-20050136103-A1 | Transepithelial delivery of effectorsequentially coupled with a counter ion to the at least one effector and at least one pharmaceutically acceptable hydrophobic agent; translocation, encapsulation | CFTR, SLC47A1, SLC47A2 | CA1 3738/4885CA2 1099/4885EEF2K 2898/4885 |
| US-20050232981-A1 | Compositions capable of facilitating penetration across a biological barrier | MMP8, PGF, AQP1 | CA1 2085/4885CA2 2227/4885EEF2K 3140/4885 |
| US-20040146549-A1 | Amino acid sequences capable of facilitating penetration across a biological barrier | SLC7A1, SLC1A5, SLC3A2 | CA1 3512/4885CA2 2769/4885EEF2K 1142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.